Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02303691 · ClinicalTrials.gov registry record · NA
Attention Bias Modification for Transdiagnostic Anxiety
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT02303691 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 70 participants.
The verdict
NCT02303691, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This project seeks to identify neural mechanisms underlying the tendency for anxious individuals to pay more attention to threatening information than to other types of information. A computerized treatment designed to train individuals to reduce their attention towards threat will be tested, with a focus on understanding the aspects of brain function that predict response to the treatment. This work could ultimately lead to the ability to treat anxiety more effectively by directly targeting the aspects of brain function that are altered in a given patient.
Interventions
- BEHAVIORAL Attention Bias Modification
- BEHAVIORAL Neutral Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2013-04 |
| Est. Completion | 2018-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02303691
The ClinicalTrials.gov registry entry for NCT02303691 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention Bias Modification is the first listed.
NCT02303691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02303691 about?
NCT02303691 is a clinical study titled "Attention Bias Modification for Transdiagnostic Anxiety". This project seeks to identify neural mechanisms underlying the tendency for anxious individuals to pay more attention to threatening information than to other types of information. A computerized treatment designed to train individuals to reduce their attention towards threat will be tested, with a...
What is the current status of trial NCT02303691?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2013-04. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02303691?
The interventions under investigation include: Attention Bias Modification (BEHAVIORAL), Neutral Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02303691?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.